PEAGUARD TABLETS (by Souhlas Pharmaceuticals)

368.00

Composition (Per Tablet)

• Palmitic Acid Monoethanolamide (PEA) – 300 mg
• Cytidine – 15 mg
• Uridine – 9 mg
• Vitamin B12 (Cyanocobalamin) – 1.1 mg
• Folic Acid – 64 mcg
• Excipients – q.s.

Nutritional Information
Contains nutrients and bioactive substances that support nerve health and cellular function.
Indications / Recommended Use
• Supports nerve health
• Promotes healthy nerve conduction
• Helps manage tingling, burning, and numbness
• Supports recovery from nerve irritation

Mechanism of Action

• PEA helps modulate chronic inflammatory pain and supports nerve signaling
• Supports relief from tingling, burning, and numbness
• Useful in sciatica and nerve compression
• Supports diabetic neuropathy
• Cytidine & Uridine support phospholipid synthesis for nerve cell membranes
• Vitamin B12 supports myelin sheath integrity
• Folic acid supports DNA synthesis and RBC formation
• Folic acid works synergistically with Vitamin B12 for nerve health

Dosage & Administration

• As directed by physician
• Typically: 1–2 tablets daily after meals

Warnings & Precautions

• Use with caution in liver or kidney impairment
• Do not exceed the recommended dose

• Not a substitute for a balanced diet
• Consult healthcare professional if pregnant, lactating, or under a medical condition

Drug Interactions

• Generally, well tolerated with minimal interactions
• Antiepileptic’s (phenytoin, carbamazepine) may reduce folate levels
• Methotrexate: folic acid may reduce toxicity
• Monitor with other vitamin supplements

Side Effects

• Nausea
• Gastric discomfort
• Bloating
• Headache
• Rare: allergic reactions (rash, itching)
• Usually mild and temporary

Storage Conditions

• Store below 25°C in a cool, dry place
• Protect from sunlight and moisture
• Keep out of reach of children
Packaging & Price
Pack size: 10X10 tablets ( or as applicable)
MRP: ₹368(inclusive of all taxes) per10 tablets

Category:

Reviews

There are no reviews yet.

Be the first to review “PEAGUARD TABLETS (by Souhlas Pharmaceuticals)”